Association of thrombocytopenia and delivery method with intraventricular hemorrhage among very-low-birth-weight infants

Am J Obstet Gynecol. 2002 Jan;186(1):109-16. doi: 10.1067/mob.2002.118268.

Abstract

Objectives: To investigate the significance of neonatal thrombocytopenia and delivery method on the incidence of intraventricular hemorrhage in infants weighing <1500 g.

Study design: A total of 1283 infants weighing <1500 g who were admitted to six neonatal intensive care units over 21 months were analyzed prospectively. Illness severity was measured by the Score for Neonatal Acute Physiology (SNAP).

Results: Of the infants analyzed, 145 (11.3%) had thrombocytopenia (platelet count <100 x 10(9)/L). The incidence of intraventricular hemorrhage was greater among infants with thrombocytopenia than among those without (44.8% vs 23.9%, P <.0001). Non-thrombocytopenic infants who were delivered vaginally had a higher incidence of intraventricular hemorrhage than those delivered via cesarean section (35.8% vs 15.9%, P <.0001). Thrombocytopenic infants who were delivered vaginally had the highest incidence of intraventricular hemorrhage (63.4% vs 37.5% for cesarean section, P =.005). Vaginal delivery and platelets < 50 x 10(9)/L on day 1 were independent risk factors for intraventricular hemorrhage (OR 2.7, 95% CI 2.0-3.8 and OR 11.2, 95% CI 3.0-42.5, respectively).

Conclusions: This multicenter study confirms that thrombocytopenia and intraventricular hemorrhage are not uncommon in neonates who weigh <1500 g, and that the incidence of intraventricular hemorrhage is higher in those thrombocytopenic infants delivered vaginally.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cerebral Hemorrhage / etiology*
  • Cerebral Hemorrhage / physiopathology
  • Cesarean Section
  • Delivery, Obstetric / adverse effects*
  • Delivery, Obstetric / methods*
  • Female
  • Humans
  • Incidence
  • Infant, Low Birth Weight*
  • Infant, Newborn
  • Multicenter Studies as Topic
  • Pregnancy
  • Prospective Studies
  • Risk Factors
  • Severity of Illness Index
  • Thrombocytopenia / complications*
  • Thrombocytopenia / epidemiology